Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2025-12-25 @ 4:03 AM
NCT ID:
NCT02556502
Eligibility Criteria:
Inclusion Criteria:
* Major subjects who have given their consent to participate in the study.
* Patients with suspected AD and whose CSF markers give intermediate results (CSF punction less than 6 months): meaning tau and/or phospho-tau increased and Ab42 / Aβ40 normal (Ab42 / Aβ40 \> 0.07).
* Non-indication to perform a PET 18F-Florbetaben.
* Affiliation to the french social security .
Exclusion Criteria:
* Patients under guardianship.
* Inability to perform a PET 18F-Florbetaben (agitated patient, confused, ..).
* Pregnancy, lactation.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02556502
Study Brief:
Protocol Section:
NCT02556502